176 related articles for article (PubMed ID: 15883282)
21. Experience with cyclosporine in endogenous uveitis posterior.
Hesselink DA; Baarsma GS; Kuijpers RW; van Hagen PM
Transplant Proc; 2004 Mar; 36(2 Suppl):372S-377S. PubMed ID: 15041371
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up of tacrolimus treatment in immune posterior uveitis.
Figueroa MS; Ciancas E; Orte L
Eur J Ophthalmol; 2007; 17(1):69-74. PubMed ID: 17294385
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
Neal DA; Gimson AE; Gibbs P; Alexander GJ
Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
[TBL] [Abstract][Full Text] [Related]
26. Infliximab in the treatment of refractory posterior uveitis.
Joseph A; Raj D; Dua HS; Powell PT; Lanyon PC; Powell RJ
Ophthalmology; 2003 Jul; 110(7):1449-53. PubMed ID: 12867408
[TBL] [Abstract][Full Text] [Related]
27. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
28. Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression.
Baan CC; van Riemsdijk-van Overbeeke IC; Balk AH; Vantrimpont PM; Mol WM; Knoop CJ; Niesters HG; Maat LP; Weimar W
Clin Transplant; 2001 Aug; 15(4):276-83. PubMed ID: 11683823
[TBL] [Abstract][Full Text] [Related]
29. Normative comparison of patient-reported outcomes in patients with noninfectious uveitis.
Naik RK; Rentz AM; Foster CS; Lightman S; Belfort R; Lowder C; Whitcup SM; Kowalski JW; Revicki DA
JAMA Ophthalmol; 2013 Feb; 131(2):219-25. PubMed ID: 23411886
[TBL] [Abstract][Full Text] [Related]
30. Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis.
Murphy CC; Duncan L; Forrester JV; Dick AD
Br J Ophthalmol; 2004 Mar; 88(3):412-6. PubMed ID: 14977779
[TBL] [Abstract][Full Text] [Related]
31. [Regulatory function of tacrolimus and CsA on CD4/CD8 T lymphocyte subgroups and costimulators on them in allo-liver recipients].
Bai YJ; Wang LL; Cai B; Zou YG; Feng WH; Yan LN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):989-92. PubMed ID: 18845086
[TBL] [Abstract][Full Text] [Related]
32. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
[TBL] [Abstract][Full Text] [Related]
33. Tacrolimus versus cyclosporine induction therapy in pulmonary transplantation in miniature swine.
Warnecke G; Avsar M; Steinkamp T; Reinhard R; Niedermeyer J; Simon AR; Haverich A; Strüber M
Eur J Cardiothorac Surg; 2005 Sep; 28(3):454-60. PubMed ID: 16054825
[TBL] [Abstract][Full Text] [Related]
34. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
[TBL] [Abstract][Full Text] [Related]
35. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
Kobashigawa JA; Patel J; Furukawa H; Moriguchi JD; Yeatman L; Takemoto S; Marquez A; Shaw J; Oeser BT; Subherwal S; Wu GW; Kawano J; Laks H
J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
[TBL] [Abstract][Full Text] [Related]
36. Keratoplasty postoperative treatment update.
Shimmura-Tomita M; Shimmura S; Satake Y; Shimazaki-Den S; Omoto M; Tsubota K; Shimazaki J
Cornea; 2013 Nov; 32 Suppl 1():S60-4. PubMed ID: 24104936
[TBL] [Abstract][Full Text] [Related]
37. Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-month follow-up.
Pollock-Barziv SM; Dipchand AI; McCrindle BW; Nalli N; West LJ
J Heart Lung Transplant; 2005 Feb; 24(2):190-4. PubMed ID: 15701436
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.
Lisowska KA; Debska-Slizien A; Radzka M; Witkowski JM; Rutkowski B; Bryl E
Artif Organs; 2010 Mar; 34(3):E77-84. PubMed ID: 20447038
[TBL] [Abstract][Full Text] [Related]
39. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
Prasad GV; Nash MM; McFarlane PA; Zaltzman JS
Nephron Clin Pract; 2004; 97(2):c35-40. PubMed ID: 15218328
[TBL] [Abstract][Full Text] [Related]
40. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
